Loop Diagnostics S.L.


Loop Diagnostics is developing a new lateral flow platform for diagnosing sepsis at the point of care. A consortium led by the Barcelona-based company recently received €150,000 ($176,000) in EU funding to bring the technology to market and current plans are to have disposable assays available commercially as soon as next year. A reader capable of multiplexing tests and undertaking quantitative measurements of reactions will soon follow. This device will allow healthcare professionals to begin accurate treatment earlier – reducing the severity of the disease and decreasing the number of antibiotics or other drugs necessary for treatment.